Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s
Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities
Market Price for Equity Securities
Our common stock is quoted on
the OTC Pink under the symbol “DWAY”. The following table sets forth the quarterly high and low daily close for our common
stock for the two years ended September 30, 2025 and 2024. There is a very limited market for the Company’s common stock
Price Range
High
Low
Year ended September 30, 2025
First Quarter
$
0.0489
$
0.0004
Second Quarter
$
0.03
$
0.0194
Third Quarter
$
0.10
$
0.012
Fourth Quarter
$
0.0878
$
0.026
Year ended September 30, 2024
First Quarter
$
0.10
$
0.0004
Second Quarter
$
0.11
$
0.0025
Third Quarter
$
0.09
$
0.02
Fourth Quarter
$
0.11
$
0.04
Holders
At January 13, 2026, the
Company had 120,025,082 outstanding shares of common stock and 151 shareholders of record.
9
Dividends
Holders of common stock are entitled
to receive dividends as may be declared by the Company’s Board. The Company’s Board is not restricted from paying any dividends
but is not obligated to declare a dividend. No dividends have ever been declared, and it is not anticipated that dividends will be paid
in the foreseeable future. Any indebtedness the Company incurs in the future may also limit its ability to pay dividends. Investors should
not purchase the Company’s common stock with the expectation of receiving cash dividends.
Recent Sales of Unregistered Securities
On November
20, 2024, the Company issued 250,000 shares of its common stock to a private investor for gross proceeds of $5,000. The issuance
to the investor relied on the exemption from registration provided by Section 4(2) of the Securities Act of 1933 and
Rule 506 of Regulation D promulgated thereunder concerning the issuance of restricted stock.
In July 2025, the Company issued 325,000 shares of
its common stock to accredited investors for $6,500 in gross proceeds. The issuance to the investor relied on the exemption from registration provided
by Section 4(2) of the Securities Act of 1933 and Rule 506 of Regulation D promulgated thereunder concerning the issuance of restricted
stock.
In August 2025, the Company issued 750,000 shares
of its common stock to an accredited investor for $15,000 in gross proceeds. The issuance to the investor relied on the exemption from registration provided
by Section 4(2) of the Securities Act of 1933 and Rule 506 of Regulation D promulgated thereunder concerning the issuance of restricted
stock.
On
October 31, 2025, the Company exchanged $25,000 in debt owed to the chief executive officer, an accredited investor, for 1,250,000 shares
of the Company’s common stock. The issuance to the investor relied on the exemption from registration provided
by Section 4(2) of the Securities Act of 1933 and Rule 506 of Regulation D promulgated thereunder concerning the issuance of restricted
stock.
On
October 31, 2025, the Company exchanged a note payable in the amount of $5,000 for 250,000 shares of the Company’s common stock
to an accredited investor. The issuance to the investor relied on the exemption from registration provided by Section
4(2) of the Securities Act of 1933 and Rule 506 of Regulation D promulgated thereunder concerning the issuance of restricted stock.
The issuance to the investor relied on the exemption from registration provided
by Section 4(2) of the Securities Act of 1933 and Rule 506 of Regulation D promulgated thereunder concerning the issuance of restricted
stock.
Purchase of Equity Securities by the Issuer
and Affiliated Purchasers
We did not repurchase any securities
during the fiscal year ended September 30, 2025.
Item 6. Selected Financial Data
As a smaller reporting company,
we are not required to provide the information required by this Item.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.